Entasis, which previously raised $50m in a Novo and AstraZeneca-backed series B last year, has added $31.9m in series B-1 round.

The corporate-backed genetic testing company is targeting a $200m funding round led by Sequoia Capital.

Teleflex is set to acquire Johnson & Johnson-backed NeoTract for a total of $1.1bn, with $725m to be paid upfront and the remainder dependent on certain milestones.

Eight Roads Ventures, the investment arm of Fidelity, has set up a healthcare fund that will focus on Chinese startups in the therapeutics, services, IT and medical technology sectors.

The University of Oxford spinout has filed for an $86.25m initial public offering in the US just three years after being founded.

General Electric and National Football League previously provided funding through the GE NFL Head Health Challenge.

GV and Celgene have returned for a $67m series C1 round in Armo Biosciences, which will use the cash to launch phase 2/3 clinical trials of its immunotherapy candidate.

CureFit Healthcare has raised funding from investors including the UC-RNT fund, a venture capital vehicle established by University of California with Ratan Tata.